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Abstract 
CAMSAP and Patronin family members regulate microtubule minus-end stability and 
localization and thus organize non-centrosomal microtubule networks, which are essential for cell 
division, polarization and differentiation. Here, we show that the C-terminal CKK domain of 
CAMSAPs is widely present among eukaryotes and autonomously recognizes microtubule minus 
ends. Through a combination of structural approaches, we uncover how mammalian CKK binds 
between two tubulin dimers at the inter-protofilament interface on the outer microtubule surface. 
In vitro reconstitution assays combined with high resolution fluorescence microscopy and cryo-
electron tomography suggest that CKK preferentially associates with the transition zone between 
curved protofilaments and the regular microtubule lattice. We propose that minus-end-specific 
features of the inter-protofilament interface at this site form the basis for CKK’s minus-end 
preference. The steric clash between microtubule-bound CKK and kinesin motors explains how 
CKK protects microtubule minus ends against kinesin-13-induced depolymerization and thus 
controls the stability of free microtubule minus ends. 
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Introduction 
Microtubules (MTs) are highly dynamic polymers, which assemble and disassemble from their 
two ends, the fast-growing plus end and the slow-growing minus end. While many data are 
available about the regulation of MT plus ends1, 2, much less is known about the proteins 
specifically regulating MT minus ends, despite the fact that MT minus end organization defines 
the architecture of cellular MT arrays3, 4. The best-studied MT nucleating and minus-end binding 
factor is the g-tubulin ring complex (g-TuRC)5. Recently, the members of calmodulin-regulated 
spectrin-associated protein (CAMSAP) and Patronin family were shown to control non-
centrosomal MT minus-end organization independently of g-TuRC in different systems, 
including the mitotic spindle in insect cells6-8, cortically attached MT arrays in epithelial cells9-13 
and MT bundles in neurons14-17. 
CAMSAP1, CAMSAP2 and CAMSAP3 (in vertebrates) and Patronin (in invertebrates) 
recognize and track uncapped, growing MT minus ends18, 19. In mammals, CAMSAP2 and 
CAMSAP3 are deposited on MT lattices formed by MT minus-end polymerization and in this 
way generate stable MT stretches that can serve as a source of non-centrosomal MT outgrowth18, 
20. In contrast, CAMSAP1 tracks growing MT minus ends but does not decorate them18. 
CAMSAPs and Patronin contain a C-terminal CKK domain (C-terminal domain common to 
CAMSAP1, KIAA1078 and KIAA1543) as well as an N-terminal Calponin Homology (CH) 
domain and several coiled-coil regions21. In mammalian CAMSAPs, the minus-end recognition 
was shown to depend on the CKK domain, while the ability of CAMSAP2 and CAMSAP3 to 
stay attached to the MT lattice was associated with additional adjacent regions18. However, in fly 
Patronin, the minus-end recognition was proposed to be mediated by the unstructured linker 
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region in combination with the adjacent C-terminal coiled coil19. The deletion of the CKK 
domain in CAMSAP3 causes a loss-of-function phenotype in mice10, and in worms, the CKK 
domain of Patronin (PTRN-1) was necessary and sufficient for supporting proper MT dynamics 
and axon regeneration17, demonstrating the functional importance of this domain.  
Here, we set out to investigate the nature of MT minus-end specificity of CAMSAPs. 
Structural analysis showed that the globular CKK domain binds to a unique site between two 
tubulin dimers at the inter-protofilament interface. Fluorescence microscopy demonstrated that 
the high-affinity site for CKK binding is located a few tubulin dimers behind the outmost MT 
minus end. Cryo-electron tomography of MT minus ends revealed a heterogeneous array of 
gently curved protofilaments that retain lateral interactions. Based on these data, we propose that 
the CKK preferentially binds to the transition zone between the regular lattice and the curved 
sheet-like structure of the minus-end extremity, which presents a subtly altered inter-
protofilament interface that is optimal for CKK binding. Finally, our structural and in vitro 
reconstitution data show that CKK sterically hinders the interaction of kinesin-13 with MT minus 
ends, explaining how CAMSAPs and Patronin protect MT minus ends against depolymerization 
by these factors. 
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Results 
Minus-end recognition by CAMSAPs depends on the CKK domain, which is conserved in 
eukaryotes 
We have previously shown that the CKK domain in mammalian CAMSAPs could bind minus 
ends18. To investigate whether other CAMSAP domains could also control minus-end 
recognition, we have tested the ability of different purified GFP-tagged CAMSAP1 and 
CAMSAP3 domains to bind to MT minus ends and lattices in vitro. None of the CAMSAP 
fragments which lacked the CKK domain showed any minus-end preference (Fig. 1a-f and 
Supplementary Fig. 1a-c). For CAMSAP1, we found that the predicted helical domain and the 
linker which precede the CKK had only very weak MT affinity, but increased MT binding, 
though not minus end selectivity of CAMSAP1 CKK (Fig.1a-f). An additional negatively 
charged linker region of CAMSAP1 (Supplementary Fig. 1d), located upstream of its third coiled 
coil domain, suppressed MT lattice binding and enhanced minus end selectivity when present 
together with the CKK domain (Fig.1a-e; this construct was termed CAMSAP1mini). For 
CAMSAP3, we confirmed that the MT binding domain located between coiled coils 2 and 3 
specifically binds to GMPCPP but not GDP MTs, as we have demonstrated previously18 
(Supplementary Fig. 1a-c). The predicted helical domain of CAMSAP3 together with the 
adjacent linker could also specifically bind to GMPCPP MTs without showing end preference 
(Supplementary Fig. 1a-c). We conclude that the minus-end preference of CAMSAPs depends on 
the CKK domains, while additional domains modulate their end selectivity or the ability to 
decorate MT lattice. 
  
 
6 
To establish whether CKK-mediated minus-end binding defines an evolutionarily 
conserved mechanism, we screened a set of nearly a hundred eukaryotic genomes and found that 
homologs of the CKK domain are found in all eukaryotic supergroups, except for Amoebozoa, 
although they were absent in some well-studied lineages such as dikaryan fungi and land plants 
(Supplementary Fig. 2 and Supplementary Table 1). Parsimoniously interpreting the occurrences 
of CKK across eukaryotes, we conclude that this domain was likely already present in the 
genome of the Last Eukaryotic Common Ancestor (LECA), and did not emerge during early 
animal evolution, as suggested previously21. In particular, our discovery of genes encoding CKK-
containing proteins in the genomes of various members of the Excavata, a group some consider 
to be sister to all other eukaryotes (discussed in 22), strongly supports an ancient origin of CKK. 
While in vertebrates the array of CKK-containing proteins was expanded by gene duplications, 
leading to the three CAMSAP paralogs in mammals, this was not the case in many other genomes 
(see Supplementary Sequence File), suggesting that in most eukaryotes a single copy of the 
domain fulfils CKK functions.  
To test whether the sequence conservation of CKK translates into functional conservation, 
we next purified GFP-tagged CKK domains derived from fly and worm (Drosophila 
melanogaster and Caenorhabditis elegans), as well as from four more evolutionarily distant 
eukaryotes (Trichomonas vaginalis, Tetrahymena thermophila, Naegleria gruberi and 
Phytophthora infestans). From these six CKK domains tested, four (D. melanogaster, C. elegans, 
T. vaginalis, T. thermophila) specifically tracked the growing minus ends of MTs assembled 
from pig brain tubulin in in vitro MT dynamics reconstitution experiments (Fig. 1g), while the 
two others (N. gruberi and P. infestans) showed strong binding along the whole MT lattice (data 
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not shown). These data demonstrate that CKK represents a protein module that recognizes MT 
minus ends, a property that is preserved over long evolutionary distances. 
 
CKK domains bind to an intra-dimer site between protofilaments 
We crystallized and solved the core structure of the mouse CAMSAP3 CKK domain (residues 
1121-1239; denoted CKK3core) by X-ray crystallography at a resolution of 1.4 Å (Table 1). 
Similar to a previously deposited but unpublished  NMR structure (PDB ID 1UGJ), the CKK3core 
has a compact, globular structure composed of two N-terminal a-helices, which are connected by 
a disordered loop (loop1) and pack against a central, five-stranded β-sheet (Supplementary Fig. 
3). 
Although CKK shows clear preference for MT minus ends, at high concentrations it can 
also decorate the whole MT lattice. We reasoned that a high-resolution structure of the lattice-
bound CKK domain might shed light on the mechanism of its MT minus-end recognition. 
Therefore, we analyzed extended CKK domains of CAMSAP1 and 3 (residues 1474-1613 and 
1112-1252, respectively) bound to 13 protofilament (pf) taxol-stabilized MTs by cryo-EM. 
Filtered images of these MTs showed extra density corresponding to CKK domains spaced by 8 
nm (Fig. 2a) indicative of binding every tubulin dimer. A striking feature of these CKK-
decorated MTs is the presence of a right-handed skew in the protofilaments. This is evident from 
both the filtered images and the alignment parameters of the MT segments used for 
reconstruction, and is specific to the CKK-MT data sets (Fig. 2a,b and Supplementary Fig. 4a). 
This indicates that CKK binding modifies the MT lattice with which it interacts, consistent with 
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the idea that the regular MT lattice conformation is not the most favored substrate for CKK 
domains.  
Asymmetric 3D reconstructions (~12 and ~9Å resolution of CAMSAP1 and CAMSAP3, 
respectively) show the CKK domains binding the MT lattice every 8 nm between protofilaments 
except at the seam (Fig. 2c and Supplementary Fig. 4b). Using the pseudo-symmetry of the MTs, 
we obtained averaged reconstructions with overall final resolutions that allowed α- and β-tubulin 
to be clearly distinguished (FSCtrue 0.143 criteria;23 of 5.3Å (CAMSAP3) and 8Å CAMSAP1) 
(Fig. 2d,e and Supplementary Fig. 4c-e, Table 2). From these data, we can conclude that CKK 
domains bind at the tubulin intra-dimer B-lattice interface where conserved differences between 
α- and β-tubulin explain this binding site selection (Fig. 3a). The binding site of CKK is distinct 
from other proteins known to bind between protofilaments, EBs and Doublecortin (DCX), which 
bind at the vertex of four tubulin dimers and not at the intra-dimer interface (Supplementary Fig. 
4f-h). However, some overlap is found with the binding site of kinesin (Supplementary Fig. 4i).  
For ease of description, the four tubulin subunits contacting a single CKK domain are 
referred to as β1-, β2-, α1- and α2-tubulin (see Fig. 2d,e and 3a). In general, the CKK wedges 
snugly between, and forms more extensive contacts with, the β-tubulins than with the α-tubulins 
(Fig. 3a). Contacts between the CKK domain and its MT binding site are distributed across the 
domain and also involve the N- and C-termini (Fig. 2d and 3a,b). To confirm and extend the 
cryo-EM data, we also analyzed the structure of the CKK domain of CAMSAP3 bound to MTs 
using solid-state NMR (ssNMR), which provides a sensitive means to study ligand and protein 
binding to MTs at the atomic level24, 25. To do this, we compared the solution NMR (PDB ID 
1UGJ) and our X-ray crystallographic results of free CKK with 2D ssNMR data recorded on 
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[13C,15N] labelled CKK in complex with MTs. This allowed us to identify CKK residues that 
underwent significant chemical-shift/intensity changes on MT binding (Fig. 3c and 
Supplementary Fig. 5a-d, labelled red) and those that experienced no significant change (labelled 
blue). For example, in our EM density, helix-α1 of the CKK domain sits across the β1- and β2-
tubulins, while beneath it, loop7 and adjacent regions of the beta barrel wedge in between the β-
tubulin subunits (Fig. 3a-c and Supplementary Fig. 5e,f). Consistent with this, residues from MT-
bound CKK helix-α1 and adjacent loop7 display ssNMR chemical shifts relative to free CKK. 
Similarly, our cryo-EM and ssNMR data corroborate interactions between CKK loop1 and β1-
tubulin, CKK loop7 and β2-tubulin, while CKK loop3 lies at the intra-dimer interface contacting 
both β1-tubulin and α1-tubulin. CKK loop8 is well positioned to form contacts with α2-tubulin, 
and our ssNMR data support the involvement of this loop in the MT interaction. However, loop8 
is only visible at less conservative cryo-EM density thresholds (Supplementary Fig. 5f) 
suggesting higher flexibility than the rest of the CKK domain in this region, consistent with its B-
factor in the crystal structure (data not shown). Taken together, residues identified as undergoing 
changes in ssNMR signals were found to cluster on the CKK MT-facing surface. In contrast, 
residues displaying unaltered ssNMR signals were found to be predominantly solvent-exposed 
(Fig. 3c and Supplementary Fig. 5b-d). The ssNMR data thus support the EM-derived binding 
mode at an atomic level. 
Neither the CKK N- and C-termini are visible in the crystal structure and both are flexible 
in solution (PDB ID 1UGJ). However, our cryo-EM and ssNMR data also support the role of the 
CKK N- and C-termini in MT binding. Density corresponding to the final portion of the N-
terminus leading into helix-α1 (starting at S1120) is visible in our cryo-EM reconstruction 
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contacting α2-tubulin (Fig. 2d, 3a,d), while additional cryo-EM density suggests that more N-
terminal regions make additional contacts with β2-tubulin (red asterisks, Fig. 3a; red dashed line 
in Fig. 3d,). The CKK N-terminus is therefore partially stabilized in complex with the MT, 
consistent with N-terminal truncation construct having lower MT affinity (Fig. 3e). Furthermore, 
although not readily modelled, cryo-EM density corresponding to the conserved, basic C-
terminus of the CKK domain and/or the β-tubulin C-terminal tail is visible (Fig. 3f). ssNMR 
measurements in the CAMSAP3 CKK-MT complex suggest that the CKK C-terminus retains 
some conformational variability when interacting with MTs (Fig. 3c). The location of the CKK 
C-terminus suggests that it interacts with the flexible acidic C-terminal tail of β1-tubulin; this is 
supported by the observation that the interaction of GFP-tagged CAMSAP3-CKK domain with 
MTs was significantly reduced when the acidic C-terminal tails of tubulin had been cleaved (Fig. 
3g).   
We also used molecular dynamics (MD) based energy calculations, which can provide an 
estimate of the relative energetic contributions of individual residues to complex formation26, to 
analyse the CKK-MT interaction. This analysis also supports the involvement of the regions 
described above in the CKK-tubulin interface (Supplementary Fig. 6a). Overall analysis of the 
electrostatic potential of the contact surfaces shows complementary charges between the CKK 
domain and the MT (Supplementary Fig. 6b,c). This is consistent with the large electrostatic 
contribution to binding energy from MD and the established sensitivity of CAMSAP-MT 
interaction to ionic strength18, 19 (Supplementary Fig. 6a,d). CKK residues at the interface with the 
MT - especially basic ones - are particularly conserved in CKK domains throughout evolution 
(Supplementary Fig. 2b and 6c,e). In addition, these calculations also highlighted the greater 
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energetic contribution of CKK binding to b-tubulin over a-tubulin (with a calculated ΔG of -
25.1±5.2 kcal/mol for b-tubulin positions compared to -3.6±5.0 kcal/mol for α-tubulin). Taken 
together, our cryo-EM, ssNMR and MD data show that CKK binds through multiple binding sites 
across two tubulin dimers at their intra-dimer interface between protofilaments, and associates 
more closely with β-tubulin. 
 
Analysis of CKK mutants supports the identified CKK-MT interface 
To further validate the identified CKK-MT binding mode, we made a series of CKK mutants in 
the context of a short version of CAMSAP1 (CAMSAP1mini, residues 1227-1613), which displays 
a more robust minus-end tracking activity than the CKK domain alone (Fig. 1a-e). Mutations of 
several conserved positively charged residues reduced the overall binding affinity of 
CAMSAP1mini to MTs and their minus ends (Fig. 4a-c), although they did not affect the integrity 
and folding of the CKK domain, as determined by measuring circular dichroism (CD) spectra and 
thermal unfolding profiles in the CAMSAP3 CKK context (Supplementary Fig. 7a). Truncation 
of the N-terminal extension or mutations of positively charged residues in this sequence had a 
similar effect, as well as truncations of the positively charged C-terminal tail region (Fig. 4a). 
These data support the validity of our CKK-MT lattice reconstruction and its relevance for CKK 
binding to the MT minus end.  
 Surprisingly, a mutation of a conserved asparagine residue (N1492 of CAMSAP1 and 
N1130 in CAMSAP3) to alanine, which did not affect the integrity of the domain (Supplementary 
Fig. 7a), dramatically increased the ability of CKK to bind to the MT lattice and reduced, though 
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did not abolish, its selectivity for minus ends (Fig. 4a-c, Supplementary Figure 7b-f). The 
importance of CAMSAP1 N1492 residue was further emphasized by the observation that 
mutating it to bulky charged or uncharged amino acids reduced the affinity of CKK for both MT 
minus ends and lattices, while substituting it for either serine or threonine enhanced MT lattice 
binding and decreased minus end selectivity even further (Fig. 4d and Supplementary Fig. 7d-f). 
CAMSAP1 N1492 is expected to contact the C-terminus of helix H4 of β2-tubulin (cyan in Fig. 
4b), and our data suggest that the formation of the CKK-MT complex is very sensitive to both to 
the size and the chemical nature of the side chain in this position. For example, the potential 
hydrogen bond formation between this residue and β-tubulin could affect the affinity of the 
CKK-MT interaction. 
We also mutated to alanine several residues close to N1492 in the CKK structure; several 
of these substitutions had no effect (Supplementary Fig. 7g,h), while the D1572A mutation also 
enhanced CKK interaction with MT lattice and reduced its minus end selectivity (Fig. 4a). 
Overall, these experiments identified two main classes of mutations: 1) mutations of positively 
charged CKK residues, which weakened the interaction between CKK and negatively charged 
surface of the MT ends and lattice, including less structurally ordered regions of both the CKK 
and MT; 2) mutations that specifically boosted lattice binding. Remarkably, these latter mutations 
were rather subtle, suggesting that the mechanism of minus end discrimination itself is also 
subtle. 
 We reasoned that understanding the mechanism underlying the improved affinity of the 
N1492A mutant for MTs would provide insight into CKK’s minus-end specificity. Therefore, we 
obtained a 3D reconstruction of the CAMSAP1 CKK N1492A mutant using cryo-EM (Fig. 4e, 
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Supplementary Fig. 8a-d, Table 2). As with the wild type CKK, the N1492A mutant also binds at 
the tubulin intra-dimer B-lattice interface with the same overall orientation as the wild type CKK 
(Supplementary Fig. 8a,c,d). However, two distinct structural properties were observed for the 
mutant: i) less protofilament skew compared to wild type in CKK N1492A decorated MTs  
(Supplementary Fig.8e) and ii) CKK N1492A itself is subtly shifted towards the main MT body 
compared to wild type (Fig. 4e). This result suggests that very small changes in the CKK-MT 
interaction determine binding selectivity of CKK between the lattice and the minus end. It also 
suggests that the adjustment in the CKK-MT interaction by the N1492A mutant – movement of 
the CKK domain deeper between protofilaments – could reflect aspects of the mechanism of end 
selectivity by wild type CKK via selection of a tubulin conformation only present at MT minus 
ends.  
We also attempted to polymerize tubulin in the presence of a high concentration of CKK. 
In the presence of the wild type CKK, only very few short microtubules formed, and instead a 
variety of tubulin oligomers were generated that formed clumps. In contrast, in the presence of 
saturating concentrations of the N1492A mutant, many longer, predominantly 13 protofilament 
microtubules formed (Supplementary Figure 8f). These data support the idea that the wild type 
CKK preferentially interacts with a polymeric conformation of tubulin that is distinct from the 
normal MT structure, while the binding of the N1492A mutant is more compatible with the 
regular MT lattice. 
 
The high affinity CKK binding site at MT minus ends is insensitive to the tubulin 
nucleotide state and lies a few tubulin dimers behind the outmost minus end  
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Having defined the CKK-MT binding mode, we set out to determine whether the state of MT 
minus ends affects CKK binding. We found that the binding of CAMSAP1mini to MT minus ends 
was insensitive to the nucleotide state of MTs, as the protein bound well to the minus ends of 
GMPCPP-stabilized (GTP like) or taxol-stabilized (GDP) MTs, as well as dynamic GTP or 
GTPγS (GDP-Pi like) MTs (Fig. 5a,b). In contrast, we observed no accumulation of 
CAMSAP1mini at depolymerizing MT minus ends (Fig. 5c), suggesting that their structure does 
not support CKK binding. 
To determine the precise localization of CKK on MT minus ends, the model-convolution 
method27, 28 was implemented to determine the relative positions of the CKK and the MT minus 
end from their one dimensional intensity profiles along the MT axis (Fig. 5d,e). Our data showed 
that CKK accumulates ~16 nm – equivalent to a few tubulin dimers - behind the outmost MT 
minus end (estimated measurement error: ~8 nm; see Methods). This result suggests that some 
structural features of MT minus ends at this specific location form a preferred CKK binding site. 
 
Cryo-electron tomography shows that inter-protofilament contacts are preserved at MT 
ends 
To get insight into the structure of this binding site, we analyzed individual ends of GMPCPP-
stabilized MTs by cryo-electron tomography (Fig. 5f). Because no averaging was imposed, the 
tomographic 3D reconstructions contain information about overall polymer configuration and 
thus directly visualises the conformation of tubulin that CKK recognises. The data quality readily 
allows discrimination of individual protofilaments and in many cases individual subunits (Fig. 
5g), and provides critical 3D information about the MT ends.  
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 Individual protofilament 3D trajectories within five minus and five plus ends (identified 
using previously established approaches29 (see Supplementary Fig.9a,b) were analyzed. Overall 
the individual MT ends are very heterogeneous, and there are no significant differences between 
minus and plus ends. However, their structures are not blunt but are also distinct from those of a 
MT end model constructed using available high resolution structures of curved tubulin 
(Supplementary Fig. 9c). First, plots of individual protofilament trajectories at both plus and 
minus ends show a range of curvatures and lengths of curved regions (see Fig. 5h for an example 
of a minus end). Second, while there is a wide variation of protofilament curvature, 
protofilaments at each end are on average less curved than in the model (Fig. 5i,j). The minus and 
plus end protofilaments are similar with respect to the length (18±15 nm and 11±8 nm at the 
minus and plus ends, respectively) and extent of longitudinal curvature, which is consistent with 
previous cryo-EM studies in 2D30, 31. This suggests that CKK minus-end preference does not 
depend on longitudinal curvature alone.  
 Intriguingly, adjacent protofilaments within a MT end retain connectivity with their 
neighbors (Fig. 5k, Supplementary Fig. 9d), even while the protofilaments spread away from the 
MT axis and the total protofilament number reduces. This behavior is in contrast to the MT end 
model in which protofilament separation is an essential consequence of their curvature and is 
more consistent with the classical “rams horns” of depolymerizing MTs31, to which CAMSAP 
does not bind (Fig. 5c). In other words, in non-depolymerizing MTs, protofilaments curving 
outwards from the MT axis flatten from a cylinder into gently curving sheet-like structures, 
which retain lateral connectivity30, 32, 33. Given that the CKK domain binds at the inter-
protofilament interface, the tomographic data suggest that potential CKK binding sites are 
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retained in the end structures we have characterised. To check whether CKK binding perturbs 
these curved sheet-like structures, we examined MT minus ends in the presence of CKK but 
detected no differences compared to the control MTs (Supplementary Fig. 9e-h). This analysis, 
when combined with our fluorescence-based localization of the CKK binding site, suggests the 
CKK prefers neither the extreme end nor the MT lattice but a transition region from the straight 
lattice to a curved and flattened polymer. 
 
The CKK domain inhibits MCAK-induced MT minus-end depolymerization by blocking its 
interaction with minus ends 
It has been shown that fly Patronin and three mammalian CAMSAPs can protect MT minus ends 
from the depolymerization by kinesin-136, 19, but the underlying mechanism is unknown. By 
superimposing HsMCAK motor structure onto our CKK-MT cryo-EM reconstruction, we noticed 
that CKK and HsMCAK would strongly clash with each other at a number of positions (Fig. 6a). 
This suggests that CKK and MCAK would compete for the binding sites at MT minus ends. To 
test this hypothesis, we measured in vitro disassembly of GMPCPP stabilized MTs by 50 nM 
MCAK in the presence of different concentrations of CAMSAP1mini or the isolated CKK domain 
(Fig. 6b,c). CAMSAP1mini and CKK almost completely inhibited the minus-end binding and 
depolymerization of MCAK at 1.5 nM and 38 nM, respectively, while the activity of MCAK on 
plus ends was largely unaffected at these concentrations (Fig. 6d,e). Above 1 µM concentration, 
even though both CAMSAP1mini and CKK fully decorated MT shaft with lattice intensities higher 
than those observed at the minus ends at low concentrations, this decoration did not lead to a 
complete inhibition of MT plus-end accumulation and depolymerization by MCAK (Fig. 6d,e). 
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This observation suggests that the CKK has the highest affinity for MT minus ends, followed by 
the MT lattice, and the lowest affinity for MT plus ends. The alternative mechanism - that 
displacement of MCAK from MT minus ends is due to CKK-mediated alteration of MT minus-
end structure which would be less favorable for MCAK binding - is not supported by our cryo-
EM images even at CKK concentration of >50 µM, which was much higher than the ones used in 
our in vitro assays (Supplementary Fig. 9e-h). This result indicates that the competition between 
CKK and MCAK on MT minus ends is primarily based on steric hindrance.   
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Discussion 
In this study, we have shown that the CKK is a highly conserved globular protein module that 
interacts with an inter-protofilament site between two tubulin dimers on the outer surface of MTs. 
Several lines of evidence suggest that an optimal site for CKK binding deviates from the inter-
protofilament interface within a regular, straight MT structure. First, the decoration by CKK 
distorts the normal MT lattice generating a right-handed protofilament skew. Second, tubulin 
copolymerisation with CKK yields mainly non-MT, curved polymers. Third, the interaction 
between CKK and its binding site is intrinsically asymmetric, with the helical parts of CKK 
interacting more closely with the β-tubulin pairs, while its connectivity with the α-tubulin pair is 
less compact and could accommodate plasticity existing at minus ends. Fourth, the N1492A 
mutation increases affinity and subtly alters the CKK position relative to the MT, resulting in a 
deeper insertion between the protofilaments. The size and the chemical nature of the N1492 
substituted side chain also affect CKK affinity for the MT lattice, suggesting that the optimal 
binding site for the wild type CKK domain might depend on specific but subtle conformational 
features of tubulin dimers at MT minus ends to allow a more buried fit between protofilaments. 
Fifth, high-resolution microscopy showed that the high-affinity CKK binding region is located, 
on average, two tubulin dimers behind the outmost MT end. This binding site fits very well with 
the average position of the transition zone between straight protofilaments in the MT shaft and 
mildly curved tubulin sheets identified at MT ends by cryo-electron tomography.  
At this transition zone, pairs of α-tubulins would be more laterally flattened and more 
flexible than the more constrained lattice-like β-tubulin pairs (Fig. 7a). Consistent with this, our 
structures show that the lattice-bound CKK already has tight shape complementarity and a large 
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contact surface with the β-tubulin pairs, whilst the α-tubulin pairs surround the CKK more 
loosely. Conversely, at the plus end, β-tubulin pairs are expected to acquire a more flattened and 
flexible arrangement than α-tubulins. This would disfavor the interaction of CKK with the plus 
end, explaining its inability to effectively compete with MCAK at this location. In summary, 
flattening of β-tubulin pairs at the plus end could squeeze CKK out of the tubulin groove to avoid 
steric clashes, whilst flattening of α-tubulin pairs at the minus end could tighten their multiple 
contacts around the CKK. This leads to a binding preference for the minus end, some capacity to 
bind the straight MT lattice and low affinity for MT plus end. The lack of CKK binding at rapidly 
depolymerizing MT minus ends, where the lateral contacts between protofilaments are expected 
to be lost due to their strong curling, is consistent with the requirement for maintenance of lateral 
protofilament connectivity and/or more gentle longitudinal curvature for CAMSAP binding.  
It is important to note that although our analysis showed that CKK is the only CAMSAP 
part which can autonomously recognise MT minus ends, some longer CAMSAP fragments, such 
as CAMSAP1mini, had a higher affinity for the minus ends. These data indicate that CAMSAP 
regions outside of the CKK domain can contribute to the affinity and selectivity of the minus-end 
binding, and additional work will be needed to decipher the underlying mechanisms. 
 The MT minus-end binding mode of the CKK domain is distinct from those of other 
known MT tip-interacting proteins. The most conceptually simple mode of MT end recognition 
relies on the presence of unique epitopes of a- and b-tubulin exposed on the outermost MT ends, 
as is the case for the g-TuRC at the minus end5, and which likely applies to the centriole protein 
CPAP at MT plus ends34. However, the preference of most known MT regulators is based on 
recognition of certain MT lattice features that are different at MT ends compared to the MT shaft. 
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For example, EB proteins bind at the corner of four tubulin dimers35, 36 and sense a GTP 
hydrolysis transition state of tubulin within the MT lattice at both plus- and minus ends37, 38. 
Doublecortin (DCX), which also binds at the corner of four tubulin dimers39, can also act as a MT 
end-binding protein and is thought to be sensitive to the extent of protofilament longitudinal 
curvature40, 41. MT depolymerizing kinesin-13s can also accumulate at MT ends, likely due to 
preference for the more curved or flexible conformations of tubulin located outside the lattice42, 43. 
Importantly, none of these mechanisms is specific for the plus or the minus end.  
CAMSAPs are similar to most other MT end-binding proteins in that they bind on the 
outer surface of MTs.: in contrast to g-TuRC, which caps MTs, CAMSAP binding is compatible 
with further MT polymerization at the minus end18. CAMSAPs and g-TuRCs thus do not directly 
compete for binding to MT minus ends; however, the restricted, lattice-like conformation of 
tubulin at g-TuRC-capped minus ends likely prevents formation of CAMSAP-preferred binding 
regions. Importantly, in contrast to EBs, CAMSAP-MT association is insensitive to the 
hydrolysis state of the tubulin-bound nucleotide. Whereas the tubulin inter-dimer interface to 
which EBs bind changes conformation in response to nucleotide, the intra-dimer interface to 
which CKKs bind does not36, 44. This accounts for the ability of CAMSAPs to recognize growing, 
GTP- as well as the GDP-bound minus ends generated by MT severing18. 
CAMSAP interaction with MT minus ends can be expected to have several consequences. 
First, by preferentially binding between laterally connected but curved protofilaments, the CKK – 
in the context of the full length protein - might inhibit formation of a regular lattice, explaining 
why CAMSAPs slow down MT minus-end polymerization18. Second, CKK binding at intra-
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dimer binding sites can also explain protection of MT minus ends from kinesin-13 driven 
depolymerization by direct steric inhibition (Fig. 7b).  
Taken together, our data show that the unique MT-binding mode of the CKK domains 
enables CAMSAPs to combine the ability to recognize MT minus ends with the preservation of 
dynamic properties of these ends. This allows CAMSAPs to be rapidly recruited to MT minus 
ends generated by release from the site of MT nucleation, severing or breakage, protect them 
against disassembly by depolymerases and, by decorating polymerizing minus ends, form 
stretches of stabilized MT lattice. Future studies will show whether there are other proteins 
sharing the CKK’s MT binding mode, or whether it is unique to this evolutionary ancient and 
widespread protein module. 
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Figure legends 
Figure 1. The CKK is a highly conserved MT minus-end tracking domain. 
(a) Schematic of the CAMSAP1 domain organization and the constructs used. 
(b-f) Total Internal Reflection Fluorescence Microscopy (TIRFM) images, corresponding 
kymographs and quantification of localization of GFP-CAMSAP1 fragments to MT minus ends 
and lattice. The intensity is normalized to the average minus-end intensity of the C4 fragment. 
Scale bars, vertical 2 min; horizontal 2 µm. Data represent mean ± SD. (d, f), n=30 MTs. 
 (g) TIRFM images and kymographs of GFP-tagged CKK domains from human (CAMSAP1), fly 
(D. melanogaster), worm (C. elegans), T. thermophila and T. vaginalis. Scale bars: horizontal, 1 
μm; vertical, 30 sec. 
See also Supplementary Fig.1 and 2, and Supplementary Table 2. 
 
Figure 2. The unique MT binding site of CAMSAP CKK domains.  
(a) Fourier filtered images of 13pf MTs. Left, filtering of a CAMSAP3-CKK decorated 13pf MT 
shows density corresponding to the CAMSAP3 CKK domain every tubulin dimer; centre, 
filtering highlights the MT moiré pattern and the presence of protofilament skew. Right, filtering 
of a kinesin-1 decorated 13pf MT highlights a comparative lack of skew. 
(b) Schematic of three sets of three protofilaments depicting the skew detected in the CKK 13pf 
MT data sets (left) compared to kinesin-bound 13pf (middle) and 14pf paclitaxel-stabilized MTs 
(right). Skew angle size is exaggerated here for ease of depiction.  
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(c) The asymmetric reconstruction of the CAMSAP3-CKK decorated 13pf paclitaxel-stabilized 
MT low-pass filtered to 15Å resolution shows extra densities (green) every 8nm corresponding to 
the CAMSAP3-CKK domain, which are absent at the seam (arrow).  
(d) The averaged reconstruction of the CAMSAP3-CKK domain viewed from the MT surface 
contacting two β-tubulins and two α-tubulins at the intra-dimer, inter-protofilament interface. 
The CKK is colored as in X-ray structure figure (see Supplementary Fig. 3) except for the N-
terminus (red) and loop1 (magenta) that are missing in our crystal structure but visible in our EM 
density. α-tubulin is shown in light grey and β-tubulin is shown in dark grey. Above, schematic.  
(e) The averaged reconstruction of the MT-bound CAMSAP3-CKK domain viewed from the MT 
lumen showing density corresponding to paclitaxel bound to β-tubulin (yellow). Along with the 
distinctive appearance of the H1-S2 and S9-S10 loops (arrowheads and arrows), this allows 
differentiation between β- and α-tubulin, and thus identification of the CKK binding site at the 
intradimer interface. Above, schematic; Ta indicates the paclitaxel binding site. 
See also Supplementary Fig. 3 and 4. 
 
Figure 3. The interaction with four tubulin monomers is distributed across the CKK 
domain.  
(a) CKK interaction surface of the MT with cryo-EM density colored according to CKK contacts 
(<6Å distance, coloring consistent with Fig. 2d). Sequence alignments for contact regions in β-
tubulin (top) and α-tubulin (bottom) indicate sequence differences between human α1a tubulin 
and β3 tubulins (*) that could contribute to CKK binding the intra- vs the inter-dimer site. 
Comparison between H. sapiens β3 tubulin, α1a tubulin (most common isoforms in mammalian 
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brain45), C. elegans (β1 tubulin, α3 tubulin), D. melanogaster (β1 tubulin, α at 84B tubulin). 
Residues contacting the CKK are within green boundaries.  
(b) 180° rotations of the CKK domain with loop coloring referring to MT contact sites in panel a. 
(c) CKK views as (b), showing ssNMR data on [13C,15N] labeled CKK decorated MTs relative 
to free CKK. Red: residues with significant chemical-shift or intensity changes, blue: no change. 
White: not analysed. The unresolved N- and C-termini are represented as dashed lines with each 
dash depicting a single residue. 
(d) CAMSAP3-CKK-MT cryo-EM density at lower threshold shows the CKK N-terminus.  
(e) TIRFM experiments show the importance of CKK N-terminal extension in MT binding. 
Intensity normalized to average CKK lattice intensity. Scale bar, 2 μm. CKK, n=104 MTs; 
CKKΔN, n=118. Data represent mean ± SD. ***, p<0.001, two-tailed Mann-Whitney U test. 
(f) CAMSAP3-CKK-MT cryo-EM density that likely corresponds to interaction between the 
CKK flexible C-terminus (blue dotted line) and β-tubulin C-terminus (grey dotted line), not 
usually seen in MT reconstructions46.  
(g). X-Rhodamine labeled paclitaxel-stabilized MTs (red), either untreated or treated with 
subtilisin to remove their C-terminal tails, incubated with 200 nM GFP-CAMSAP3-CKK and 
imaged using TIRFM. Scale bar, 4 μm. The intensity of MT labelling, normalized to wild type, 
was quantified; n=100 MTs. Data represent mean ± SD. ***, p<0.001, two-tailed Mann-Whitney 
U test. 
See also Supplementary Fig. 5 and Supplementary Table 2. 
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Figure 4. Validation of CKK-MT contact sites using in vitro assays and structure of a 
mutant CKK bound to MTs.  
(a) Left, TIRFM images of GFP-CAMSAP1mini wild type and mutants binding to the minus ends 
of dynamic MTs. The corresponding residues in CAMSAP3 and their location are indicated. 
Scale bar, 1 μm. Right, quantification of GFP-CAMSAP1mini intensities at MT minus ends and on 
MT lattice. The intensity is normalized to the average minus-end intensity of wild type. n ranged 
from 17 to 87 MTs; individual data points are provided in Supplementary Table 2.  Data 
represent mean ± SD.  
(b) View of the CKK interaction surface of the MT cryo-EM density with mutated CKK residues 
mapped (<8Å distance) and colored according to the % change in minus-end fluorescence signal 
relative to wild type of corresponding mutants (panel a).  
(c) Surface representation of the tubulin-interacting face of the CAMSAP1 CKK domain. 
Mutated CKK residues are colored according to the % change in minus-end fluorescence signal 
of corresponding mutants relative to wild type in our TIRF assays (as in panel a).  
(d) Left, TIRFM images of GFP-CAMSAP1mini N1492 mutants; Scale bar, 1 μm. Right, 
quantification of GFP-CAMSAP1mini intensities at MT minus ends and on MT lattice. The 
intensity is normalized to the average minus-end intensity of wild type. n=30 MTs. Scale bar, 1 
μm 
(e) The N1492A CAMSAP1 CKK binds at the intra-dimer, inter-protofilament MT binding site 
but in a subtly different orientation compared to wild type. Ribbon representation comparing the 
position of N1492A CAMSAP1 CKK with wild type CAMSAP1 CK relative to the tubulin-
binding surface. N1492A CAMSAP1 CKK (shown in blue) is rotated 5° (around the indicated 
  
 
34 
axis) and translated 1.9Å into the inter-protofilament binding site compared to wild type 
CAMSAP1 CKK (green). Arrowhead depicts position of N1492. 
See also Supplementary Fig. 7 and 8, and Supplementary Table 2. 
 
Figure 5. Examining CKK’s preferred tubulin conformation.  
(a) TIRFM images of the minus-end localization of GFP-CAMSAP1mini on GMPCPP or taxol-
stabilized MTs. Scale bar, 1 μm. 
(b) Kymographs showing that GFP-CAMSAP1mini tracks growing MT minus ends whether MTs 
are polymerized in the presence of GTP or GTPγS, while mCherry-EB3 decorates the whole 
lattice of GTPγS MTs. Scale bars: horizontal, 1 μm; vertical, 30 sec. 
(c) Kymograph showing that GFP-CAMSAP1mini tracks a growing but not a depolymerizing MT 
minus end (white arrow). Scale bars: horizontal, 1 μm; vertical, 5 sec. 
(d) A TIRFM image of Rhodamine-labeled stable GMPCPP MT and CAMSAP1mini-GFP. 
Normalized one-dimensional intensity profiles of CAMSAP1mini-GFP and MT and corresponding 
fitting of point spread function-convoluted models (see Methods for details). To reduce the error 
introduced by the flexible linker between CKK and GFP, GFP was inserted at the CKK C-
terminus. Scale bar, 200 nm. 
(e) Distribution of the position of CAMSAP1mini-GFP relative to the MT minus end 
(mean±SEM). N=163 MTs. 
(f) Projection image from a cryo-ET tilt-series showing in vitro GMPCPP-MTs including several 
ends. The moiré patterns were used to determine MT polarity (see Supplementary Fig. 9). The 
black dots are gold fiducials for tilt series alignment.  
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(g) Longitudinal slice through MTs in the tomographic volume corresponding to the boxed region 
in panel f.  
(h) 2D graphical representation of an exemplar minus end, plotting 3D pf trajectories. In this 14 
pf MT, 7 pfs are plotted on either side, numbered around the circumference (pf14 is adjacent to 
pf1).  
(i) Sagittal slices through tomographic volumes showing a range of curvatures and lengths at both 
ends. Some pfs terminate in the lattice before curvature is observed.  
(j) Longitudinal curvature of ends. Only curved end regions > one dimer long are plotted. Inset; 
schematic of longitudinal curvature A-B. Model End (Supplementary Fig. 9c), n=14 
protofilaments; Plus End, n=32 protofilaments (5 MTs), Minus End, n=38 protofilaments (5 
MTs). Data represent mean ± SD. Minus End vs Plus End not significant; model vs data, 
statistically significant (p<0.01) Kolmogorov-Smirnov test.  
(k) Series of transverse sections through a MT from lattice to end. Lower panels show traced pf 
positions.  
See also Supplementary Fig. 9 and Supplementary Table 2. 
  
Figure 6. CAMSAP CKKs protect MT minus ends from MCAK-induced depolymerization 
via steric inhibition. 
(a) A MT tubulin dimer-pair bound to CAMSAP3-CKK (green) is shown with the expected 
position of an MD of human MCAK (in complex with ADP; PDB ID 4UBF) by alignment with 
MT-bound kinesin-147 in Chimera48.  
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(b) Kymographs of MT depolymerization assay with GMPCPP-stabilized MTs (blue) and GFP-
MCAK (red). MT polarity was determined based on the movement of the SNAP-Alexa647-
tagged plus-end directed motor kinesin-1 KIF5B (green, residues 1-560). Scale bars: horizontal, 1 
μm; vertical, upper panel, 1 sec, lower panels, 1 min. 
(c) Kymographs of MT depolymerization assays with GMPCPP-stabilized MTs (blue), GFP-
MCAK (red) and different concentrations of SNAP-Alexa 647 CAMSAP1mini or CKK (green). 
Scale bars: horizontal, 1 μm; vertical, 1 min. In panels (b) and (c), MT minus (-) ends are shown 
on the left and plus (+) ends on the right. 
(d-e) Quantification of MT depolymerization rate, MCAK intensity and CAMSAP1 intensity at 
different concentrations of CAMSAP1mini (d) or CKK (e). n ranged from 17 to 31 MTs; individual 
data points are provided in Supplementary Table 2. Data represent mean ± SD.  
See also Supplementary Table 2. 
 
Figure 7. Proposed mechanisms of MT minus end binding and protection from MCAK-
induced depolymerization by the CKK domain.  
(a) Towards the ends of stable or growing MTs there is a transition from the regular lattice to 
sheet-like regions, with increasing longitudinal curvature and decreasing lateral curvature. 
Protofilaments retain lateral connectivity, and thus inter-protofilament CKK binding sites are 
preserved. Given the polar nature of MTs, these lattice-sheet transitions create unique 
conformations of B-lattice tubulin dimer-pairs at either end of the MT: at the minus end, α-
tubulins in dimer-pairs are more flattened compared to β-tubulins, with the opposite being true at 
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the plus end. In this way, we propose that the unique dimer-pair conformation at the minus end 
favors CKK binding when compared to dimer pair conformations in the lattice or at the plus end.  
(b) Model of minus end (-end) specific protection from MCAK-induced depolymerization by the 
CKK domains. CKKs (green circles) bind specifically to a curved minus end region, preventing 
the association of MCAK motor domains (red triangles) to the same region via steric inhibition. 
As the CKKs do not bind to the corresponding region of the plus end (+end), MCAK is free to 
bind and depolymerise from the plus end. 
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Table 1 Data collection and refinement statistics (molecular replacement) 
 
       CKK3 
     (5LZN) 
 
Data collection   
Space group          I422  
Cell dimensions      
    a, b, c (Å)  96.4, 96.4, 63.3  
    a, b, g (°)   90.0, 90.0, 90.0  
Resolution (Å) 68.1-1.4 (1.45-
1.4) 
 
Rmeas (%) 
Rpim (%)                                              
       6.8(475.0) 
       1.3(99.2) 
 
I/s(I)       23.5 (0.8)  
CC1/2       100 (52.2)  
Completeness (%)       100 (99.9)  
Redundancy       25.5(22.4)  
   
Refinement   
Resolution (Å)       68.1-1.4  
No. reflections         29557  
Rwork / Rfree       16.2/19.2  
No. atoms             
    Protein           897  
    Water            67  
B factors   
    Protein          46.0  
    Water          45.5  
R.m.s. deviations   
    Bond lengths (Å)          0.01  
    Bond angles (°)          1.33  
 
Data were collected from one crystal 
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Table 2. Cryo-EM data collection, refinement and validation statistics 
 
  CAMSAP3 CKK          
taxol-GDP 
13pf MTs 
(EMD-4154, 5M50) 
 CAMSAP1 CKK          
taxol-GDP 
13pf MTs 
 (EMD-4156, 5M54) 
CAMSAP1   N1492A 
CKK taxol-  GDP 
13pf MTs 
 (EMD-3444, 5M5C) 
Data collection and 
processing 
   
Magnification     41,720    41,477    35,971 
Voltage (kV)  300Kv   200Kv             300Kv 
Electron exposure (e–/Å2)                25   20   25 
Defocus range (μm)                                       -0.4 to -3.5μm   -0.4 to -3.5μm    -0.4 to -3.5μm 
Pixel size (Å) 1.534Å 1.543Å   1.39Å 
Symmetry imposed*      Pseudo-helical                Pseudo-helical   Pseudo-helical 
Initial particle images (no.) 66,453 34,122    36,027           
Final particle images (no.) 6,530  5,954    4,144 
Map resolution (Å) 
FSC threshold† 
5.3Å 
FSCtrue 0.143 
 8Å 
 FSCtrue 0.143 
   4.8Å 
   FSCtrue 0.143 
Map resolution range (Å)             5-6.5Å   7.5-8.5Å    4.5-6Å 
    
Refinement    
Initial models used   5LZN, 1UGJ, 3J6G  5LZN, 1UGJ, 3J6G 5LZN, 1UGJ, 3J6G 
Refinement resolution (Å) 
FSCaverage 
              6.5 
0.81 
8 
 0.91 
 5.5 
 0.83 
Map sharpening B factor (Å2) -200 -350 -120 
Model composition 
    Nonhydrogen atoms 
    Protein residues 
    Ligands 
 
14,600 
1826 
6 
 
14,605 
1825 
6 
 
14,608 
1826 
6 
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0 
0.78 
 
0 
0.72 
 
0 
0.79 
 Validation# 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)    
 
1.70 
8.94 
0 
 
1.61 
7.15 
0 
 
1.70 
7.4 
0.06 
Ramachandran plot# 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
96.58 
100 
0 
 
96.58 
100 
0 
 
95.75 
100 
0 
 
*Microtubules exhibit pseudo-helical symmetry due to a symmetry break at the seam. As CKK domains do not bind 
at the seam, 12-fold pseudo-helical symmetry was applied to the 13pf microtubule reconstructions. 
 
†The FSC curves for all reconstructions were subjected to the gold-standard noise-substitution test for overfitting23. 
The resolution value at the gold-standard FSCtrue 0.143 criterion is shown. 
 
#As defined by the MolProbity49 validation server. 
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Online Methods 
Sequence analysis 
For the detection of CKK homologs BLASTP/PSI-BLAST50 and phmmer/jackhmmer51 searches 
were performed online across the nr and UniProt databases, respectively, taking different 
sequences as query. Based on these hits, a multiple sequence alignment was made with 
MAFFT52, version v7.149b, option einsi make an HMM profile. This profile was used to search 
for other sequences containing the CKK domain across our own dedicated set of eukaryotic 
proteomes (Supplementary Table 1). The resulting full-length protein sequences can be found in 
Supplementary Sequence File. 
  
Protein expression and purification for crystallization 
The DNA encoding the Mus musculus CAMSAP3 CKK core domain (denoted CKK3core, residues 
1121-1239; Uniprot: Q80VC9) was amplified from the Mus musculus CAMSAP3 CKK domain 
vector (denoted CKK3) (residues 1112-1252) and cloned into the pET-based bacterial expression 
vector PSTCm2 (with an N-terminal 6x His-tag) by the positive selection methods53. The CKK3 
and the mutants for biophysics characterization were cloned into the pET28a vector. Protein 
production was performed in the Escherichia coli strain BL21(DE3) (Stratagene) in LB media 
containing 50 µg/ml kanamycin. When the one liter cultures had reached an OD600 of 0.6 at 37 °C, 
the media were cooled down to 20 °C and the expression was induced with 1 mM isopropyl 1-
thio-β-D-galactopyranoside (IPTG). The expression was conducted for 16 hours at 20 °C. After 
harvesting and washing the cells with Dulbecco PBS (Millipore), the cells were sonicated in the 
presence of the protease inhibitor cOmplete cocktail (Roche) in lysis buffer (50 mM HEPES, pH 
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8, supplemented with 500 mM NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol, 0.1% bovine 
deoxyribonuclease I).  
Proteins were purified by immobilized metal-affinity chromatography (IMAC) on a HisTrap HP 
Ni2+-Sepharose column (GE Healthcare) at 4 °C following the instructions of the manufacturer. 
The column was equilibrated in IMAC A buffer (50 mM HEPES, pH 8, supplemented with 500 
mM NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol). Proteins were eluted by IMAC B buffer 
that contained 400 mM imidazole after washing with 5 % IMAC buffer B. In the case of 
CKK3core, the N-terminal His-tag was cleaved off by an in-house produced HRV 3C protease in 
IMAC A buffer for 16 hours at 4 °C. The cleaved sample was applied again on the IMAC column 
to separate cleaved from uncleaved protein.  
Proteins were concentrated and loaded on a SEC HiLoad Superdex 75 16/60 column (GE 
Healthcare) that was equilibrated in 20 mM Tris-HCl, pH 7.5, supplemented with 150 mM NaCl 
and 1 mM DTT. The fractions of the main peak were pooled and concentrated to 10 mg/ml. 
Protein quality and identity were assessed by SDS-PAGE and mass spectrometry, respectively. 
 
Protein expression and purification for cryo-EM 
Human CAMSAP1 wild type, N1492A CKK (residues 1474-1613) and mouse CAMSAP3 CKK 
(residues 1112-1252) were cloned into pET28a vector. Following the purification using Ni-NTA 
resin (Qiagen), proteins were further purified on an ion exchange column MonoS and gel 
filtration column Superose 6 (GE Healthcare). Purified proteins were concentrated to ~20 mg/ml 
in BRB20 buffer. 
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Protein expression and purification for in vitro assays 
All proteins used for Total Internal Reflection Fluorescence microscopy (TIRFM) (human 
CAMSAP1 CKK (residues 1474-1613) and CAMSAP1mini (residues 1227-1613), fly CKK 
(residues 1547-1689), worm CKK (residues 982-1128), Tetrahymena thermophila CKK (residues 
1635-1770), Trichomonas vaginalis CKK (residues 650-795), Naegleria gruberi CKK (residues 
612-788), Phytophthora infestans CKK (residues 1120-1168), human MCAK full length and 
human KIF5B (residues 1-560)) were expressed in HEK293T cells using modified pTT5 
expression vector (Addgene, #44006,54) bearing strep-GFP or strep-SNAP tag at either N- or C 
terminus of the protein. The CKK cDNA sequences encoding T. thermophila, T. vaginalis, N. 
gruberi were codon optimized for human cell expression and synthesized as gBlock from IDT.  
The CKK of P. infestans was obtained by PCR from genomic DNA (a gift from Dr. F. Govers, 
Wageningen University). Fly and worm Patronin cDNAs were kindly provided by Dr. V. Gelfand 
(Northwestern University) and Dr. M. Harterink (Utrecht University), respectively. In 
CAMSAP1mini-GFP protein, the GFP tag was inserted directly after the C-terminus of the CKK 
domain followed by a short flexible linker (CAMSAP1 residues 1227-1613-GGSGGS-GFP) 
Cells from one 15 cm dish collected after 36 hrs transfection were lysed in 900 μl lysis 
buffer (50 mM HEPES, 300 mM NaCl, 0.5% Triton X-100, pH 7.4) supplemented with protease 
inhibitors (Roche). After clearing debris by centrifugation, cell lysates were incubated with 100 
μl StrepTactin beads (GE Healthcare) for 45 mins. Beads were washed 5 times with lysis buffer 
without protease inhibitors and twice with the wash buffer (50 mM HEPES, 150 mM NaCl and 
0.01% Triton X-100). The proteins were eluted in 60 μl elution buffer (50 mM HEPES, 150 mM 
NaCl, 0.01% Triton X-100 and 2.5 mM desthiobiotin).  
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To label SNAP tagged proteins with Alexa-647 dye (NEB), 20-40 μM dye was incubated 
with proteins on beads for 1 hr between the washing and elution steps. After extensive washing 
steps, proteins were eluted in elution buffer containing 300 mM instead of 150 mM NaCl. 
HEK293T cell line was obtained from ATCC, was not found in the database of commonly 
misidentified cell lines maintained by ICLAC and NCBI BioSample, was not authenticated and 
was negative for mycoplasma contamination.  
 
Total Internal Reflection Fluorescence microscopy (TIRFM) 
TIRFM was performed on an inverted research microscope Nikon Eclipse Ti-E (Nikon) with the 
perfect focus system (PFS) (Nikon), equipped with the Nikon CFI Apo TIRF 100x 1.49 N.A. oil 
objective (Nikon), Photometrics Evolve 512 EMCCD (Roper Scientific) and controlled with the 
MetaMorph 7.7 software (Molecular Devices). Images were projected onto the chip of Evolve 
512 camera with intermediate lens 2.5X (Nikon C mount adapter 2.5X). To keep in vitro samples 
at 30°C, we used stage top incubator INUBG2E-ZILCS (Tokai Hit).  
For excitation we used 491nm 100mW Stradus (Vortran), 561nm 100mW Jive (Cobolt) 
and 642 nm 110 mW Stradus (Vortran). We used ET-GFP 49002 filter set (Chroma) for imaging 
of proteins tagged with GFP, ET-mCherry 49008 filter set (Chroma) for imaging X-Rhodamine 
labelled tubulin or mCherry-EB3 and ET-405/488/561/647 for imaging SNAP-Alexa647. For 
simultaneous imaging of green and red fluorescence, we used the triple-band TIRF polychroic 
ZT405/488/561rpc (Chroma) and the triple-band laser emission filter ZET405/488/561m 
(Chroma), mounted in the metal cube (Chroma, 91032) together with Optosplit III beamsplitter 
(Cairn Research Ltd, UK) equipped with a double emission filter cube configured with 
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ET525/50m, ET630/75m and T585LPXR (Chroma). We used sequential acquisition for triple 
colour imaging experiments. 
 
In vitro MT assays 
The in vitro assays with dynamic MTs were performed under the same conditions as described 
previously18. Briefly, after functionalizing coverslips by sequentially incubating them with 0.2 
mg/ml PLL-PEG-biotin (Susos AG, Switzerland) and 1 mg/ml neutravidin (Invitrogen) in 
MRB80 buffer, GMPCPP-stabilized MT seeds were attached to coverslips through biotin-
neutravidin interactions. Flow chambers were further blocked with 1 mg/ml к-casein. The 
reaction mix with purified proteins (MRB80 buffer supplemented with 20 μM porcine brain 
tubulin, 0.5 μM X-rhodamine-tubulin, 75 mM KCl, 1 mM GTP, 0.2 mg/ml κ-casein, 0.1% 
methylcellulose and oxygen scavenger mix (50 mM glucose, 400 μg/ ml glucose oxidase, 200 μg/ 
ml catalase and 4 mM DTT) was added to the flow chamber after centrifugation. The flow 
chamber was sealed with vacuum grease, and dynamic MTs were imaged immediately at 30ºC 
using a TIRF microscope.  
The conditions for MT depolymerisation assay were essential the same as in the assays 
with dynamic MTs except that tubulin proteins were not included and the reaction mix was 
optimized to image MT depolymerisation (MRB80 buffer supplemented with 100 mM KCl, 1 
mM GTP, 1 mM ATP, 0.2 mg/ml κ-casein and oxygen scavenger mix). All tubulin products were 
from Cytoskeleton. 
 
Quantification of the intensity of the wild type and mutant CAMSAP1mini on dynamic MTs 
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To quantify the minus-end and lattice intensity of CAMSAP1mini in a time-lapse movie, 
kymographs were generated in ImageJ using KymoResliceWide plug-in. The minus-end 
positions were marked by 5-pixel wide linear ROIs corresponding to CAMSAP1 mini signals. The 
maximum intensity within 5-pixel region along the spatial axis of the kymograph was measured 
by using a Macro written in ImageJ. 
 
Determination of CAMSAP1 position on MT ends 
To determine the position of CAMSAP1mini relative to the MT minus end, we simultaneously 
imaged CAMSAP1mini-GFP and X-Rhodamine labelled GMPCPP stabilized MTs using a beam 
splitter. Spatial registration between two channels was performed by B-spline point based 
transform (MathWorks File Exchange: 20057-b-spline-grid--image-and-point-based-registration) 
using images of a calibration grid featuring 500 nm diameter transparent circles separated by 2 
μm distance (Compugraphics, UK). In order to achieve better spatial sampling of imaging area, 
an image of “denser” grid was obtained by moving the stage eight times with the step of 0.25 μm 
in both x and y direction during calibraion. After channel’s registration, we extracted one-
dimensional intensity profiles along MT axis for both CAMSAP1mini and MT channels. The 
profiles were fitted to the models previously used for XMAP215 and MT ends28. Briefly, MT end 
axis profile was modelled as an error function, which is the result of convolution between step 
function representing density of tubulin molecules distribution in a MT and a Gaussian 
representing the optical point spread function (PSF) of the microscope. CAMSAP1mini axis profile 
was modelled as the combination of Gaussian peak (representing convoluted point like 
accumulation at the edge of the minus-end) and error function (accounting for its weak lattice 
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binding) with different weights. The PSF size estimation (GFP channel: 108 nm; x-Rhodamine 
channel: 125 nm) was obtained from two colour images of 100 nm diameter fluorescence beads 
(TetraSpeck, Invitrogen).  
The overall displacement error between point images in two channels after registration 
was estimated to be ~2 nm. It based on acquiring an extra set of calibration grid images and 
calculating the average distance between corresponding spots in two channels after registration. 
The average error of fitting for the position parameters is about 5 nm and 6 nm for CAMSAP1 
(peak position) and MT (edge position), respectively. Thus, according to the propagation of 
uncertainty the estimated error of a distance between the peak of CAMSAP1 distribution and the 
edge of MT minus-end is about 2" + 5" + 6" ≈ 8 nm. 
 
Structure determination of the CAMSAP3 CKK domain 
CKK3core was concentrated to 14 mg/ml and TCEP to a final concentration of 5 mM was added. 
The screening of crystallization conditions was performed using a Mosquito robot (TTP Labtech) 
in 96 wells plate using the vapor diffusion hanging drop method. In drops of a 1:1 (200 nl each) 
mixture of CKK3core and mother liquor (100 mM citric acid, pH 5, 1 M NaCl) crystals with a 
diameter of 100 μm appeared after one week. The crystals were cryo-protected by transfer into 
mother liquor supplemented with 10% glycerol and were flash frozen in liquid nitrogen.  
Diffraction data were collected at the X06DA macromolecular crystallography beamline at the 
Swiss Light Source (Paul Scherrer Institut) at a wavelength of 1 Å. The data were indexed with 
LABELIT55, refined and integrated in XDS56. The crystals diffracted up to 1.4 Å at a wavelength 
  
 
47 
and the crystals belonged to the space group I422 with a = 96.4 Å, b = 96.4 Å and c = 63.3 Å. 
The structure was solved by molecular replacement using PHASER57 with the available NMR 
structure (PDB ID 1UGJ) as a search model. Several rounds of manual model building in 
COOT58 and refinement in PHENIX.refine59 and REFMAC560 produced a final model with 
satisfactory R-work/R-free. The structure was validated by MolProbity and the wwPDB 
Validation Service. Figures were created using PyMOL61. Data collection and refinement 
statistics are given in Table 1.  
 
Circular dichroism (CD) spectroscopy 
CD spectra of CKK3 and derived mutants were recorded on a Chirascan-Plus CD instrument 
(Applied Photophysics Ltd.) equipped with a computer-controlled Peltier element using a cuvette 
of 1 mm optical path length. 0.25 mg/ml of protein sample was applied in PBS buffer. Thermal 
unfolding profiles were measured at 206 nm by continuous heating at 1°C min−1. 
 
MT pelleting assays 
MT pelleting assays of purified proteins were performed as previously described62. Briefly, 10 
mg/ml bovine brain tubulin was diluted in 1x BRB35 buffer (35 mM K-PIPES, pH 6.8, 
supplemented with 1 mM EGTA, 1 mM MgCl2, 1 mM DTT) to 1 mg/ml. After the addition of 
0.5 mM GTP, the sample was incubated on ice for 5 minutes. MT polymerization was started by 
the transfer to 37 °C. After 10 minutes, 0.1 µM, 1 µM and 10 µM paclitaxel were added stepwise 
with incubation times of 5 minutes each. Pelleting assays in the presence of CAMSAP3-CKK 
were performed by mixing 3.8 µM of taxol-stabilized MTs with an equimolar ratio of the 
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CAMSAP3-CKK in the presence of different amounts of sodium chloride concentrations. As 
controls, taxol-stabilized MTs or the CAMSAP3-CKK was applied alone. Samples were applied 
onto a taxol-glycerol cushion that contained 55% 2x BRB35, 44% Glycerol and 6% 2 mM 
paclitaxel. After centrifugation at 174,500 x g for 30 min at 25 °C, an aliquot was taken from the 
supernatant. After removing the supernatant the pellet was resuspended into SDS sample buffer. 
Samples were loaded and analyzed on Coomassie stained 15% SDS gel.  
 
Cryo-EM methods summary (details are provided in the Cryo-EM Methods Supplemenatary 
note) 
Single particle cryo-EM data of MT-CAMSAP3 CKK domain complexes were collected on a 
Tecnai G2 Polara (FEI), while data of MT-CAMSAP1 CKK domain complexes were collected 
on a Tecnai F20 (FEI), both using a DE20 direct electron detector (Direct Electron). Data of MT-
CAMSAP1 N1492A mutant CKK domain complexes were collected on a Tecnai G2 Polara using 
a K2 direct electron detector (Gatan) operating in counting mode. Cryo-electron tomography 
single-axis tilt series of MT ends were collected on a Tecnai G2 Polara on a K2 summit direct 
electron detector (Gatan) operating in counting mode. MTs for single particle reconstruction were 
boxed manually, and were input to a set of custom-designed semi-automated single-particle 
processing scripts utilizing Spider and Frealign as described previously63, 64. The final dataset 
sizes and resolutions are reported in Table 2. For the cryo-ET data, tilt series were processed and 
tomograms generated using IMOD’s Etomo graphical user interface (v4.7.15).  
 
CKK domain-MT pseudo-atomic model building 
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The X-ray structure of the CAMSAP3-CKK domain (PDB ID 5LZN) was rigidly fitted into CKK 
domain density of CAMSAP3-CKK domain map using UCSF Chimera’s ‘fit in map’ tool. A 
homology model of CAMSAP1-CKK (residues 1474-1600) was generated using MODELLER65, 
based on the CAMSAP3-CKK crystal structure as template. In order to model missing loops and 
terminal regions for both CKKs, the deposited NMR structure of the CAMSAP3 CKK domain 
(PDB ID 1UGJ) was used as template. CKK models were selected based on MODELLER’s 
statistical potentials score - zDOPE66. The model of CAMSAP1-CKK was rigidly fitted into its 
density map and for both CKKs, the local fits of secondary-structural elements and loops were 
scored with a local correlation score using TEMPy (SCCC,67. Loop regions which had low SCCC 
scores, were further optimized. For each of these loops, 200 loop-models were generated using 
MODELLER loop optimization protocol68 and a top-scoring conformation (based on SCCC) was 
selected. To create the N1492A CAMSAP1 CKK model, the point-mutation on the wild type 
CAMSAP1 model was performed in Coot69 and this was rigidly fitted into the corresponding 
mutant CKK density. 
Final CKK fits were combined with rigid fits (using Chimera’s ‘fit in map’) of two 
tubulin dimers from the structure of the paclitaxel stabilized-MT44(PDB ID 3J6G). The rigid 
fitted models were already a good fit to experimental density, therefore the models underwent 
final refinement to their Bfactor sharpening resolutions (Table 2) with NCS restraints using the 
phenix.real_space_refine tool in Phenix70 to resolve clashes and improve model geometry. The 
MolProbity validation indicated zero Ramachandran outliers, 98.1 % Ramachandran favored 
residues, zero rotamer outliers and a clash score of 0.56. 
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Molecular dynamics simulations 
4000 cycles of energy minimization without any positional restrains were performed on the 
refined structural complexes. Two consecutive molecular dynamics simulation runs of 10ps and 
200ps were then employed to increase the temperature from 100K to 300K and to equilibrate the 
systems at 300K. Four replicate production runs of 40ns each were then performed starting from 
the equilibrated system configurations. The simulations were run at constant temperature (300K) 
and constant pressure (1atm) using a 2fs time step. Periodic boundary conditions and full particle-
mesh Ewald electrostatic were used. A 12Å cutoff value was applied to truncate the non-bonded 
interactions. The SHAKE algorithm was used to constrain the covalent bonds formed by 
hydrogen atoms. Each replicate simulation was run with different random starting velocities. 
 
MM/GBSA calculations 
Molecular mechanics with generalized Born and surface area solvation (MM/GBSA) calculations 
were performed with the GBOBC model (6) in AMBER 12 (1). For each molecular dynamics 
simulation, pairwise energetic interactions values (flag idecomp=4) were scaled by the average 
number of CKK domain – tubulin dimers contacts (51 contacts) and averaged over four replica 
simulations. 
 
NMR sample preparation and experiments 
Uniformly [13C,15N] variants of CKK were produced in Escherichia coli strain Rosetta 2 in M9 
minimum media containing 25 µg/ml kanamycin and 35 µg/ml chloramphenicol. The cells were 
induced with 0.3mM IPTG at 25 °C for overnight after OD600 reached 0.6. Proteins were purified 
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as described above with phosphate buffer instead of HEPES buffer. After purification, proteins 
were loaded onto a SEC HiLoad Superdex 75 26/60 column (GE Healthcare), which was 
equilibrated in 40 mM phosphate buffer with 150 mM NaCl and 1 mM DTT, pH 7.0. Proteins 
were then concentrated and used for solution-state NMR measurement supplemented with 5% 
D2O, or ssNMR sample preparation.  
For ssNMR experiments, [13C,15N]-CAMSAP3-CKK/MT complex was prepared. 20 mg 
of lyophilized tubulin was first dissolved in BRB80 buffer to make a final concentration of 2 
mg/ml. Tubulin was then polymerized with addition of 20μM paclitaxel for 30 minutes at 37 °C. 
Paclitaxel-stabilized MTs were centrifuged at 55,000 rpm (Beckman TLA-55 rotor) at 30 °C for 
30 minutes. The pellet was resuspended in warm BRB80 buffer and labeled CKK domain was 
added to the final concentration of 65.3 µM (CKK:tubulin ratio 4:1). The mixture was incubated 
at 37 °C for 30 minutes and then centrifuged at 55,000 rpm (Beckman TLA-55 rotor) at 30 °C for 
30 minutes. The pellet was washed with phosphate buffer without disturbing the pellet. Finally, 
the pellet was transferred and packed into a 3.2 mm rotor. 
Resonance assignments were obtained from previous results (PDB ID 1UGJ) and additional 
solution-state NMR experiments on free CKK were recorded on a 600MHz spectrometer (Bruker 
Biospin) to assign missing residues (2D HSQCs, 3D HNCA, HNCO, HNCACB, CBCA(CO)NH, 
HAHB(CO)NH, hCCH-DIPSI). Solid-state NMR experiments involved two-dimensional NCA 
and CC Proton-driven spin diffusion (PDSD) experiments (temperature 260 K, MAS rate 14 
kHz) as well as additional 2Q-1Q experiments (temperature 268 K, MAS 10 kHz). Mixing 
schemes employed SPECIFIC-CP transfers71 as well as SPC572 and Spin diffusion under weak 
coupling conditions73 for longer PDSD mixing times. Data were recorded on a 950 MHz 
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standard-bore spectrometer (Bruker Biospin) equipped with a 3.2mm triple-channel MAS HCN 
probe. ssNMR data were analyzed using NMR assignments obtained on free CKK as a reference. 
Resolved residues for which signal matched with ssNMR data within 0.5 ppm in 13C and 1 ppm 
in 15N dimensions74 were considered as unperturbed, while resolved residues for which signal 
matched with ssNMR data within 1 ppm in the indirect dimension and 0.5 ppm in the direct 
dimension in the CC PDSD experiments were considered as unperturbed. Larger deviations were 
considered as altered and indicated in red.  
 
Analysis of CKK domain binding to subtilisin-treated MTs 
Paclitaxel-stabilized MTs were prepared containing 10% rhodamine tubulin, 10% biotinylated 
tubulin, and 80% unlabelled tubulin (Cytoskeleton, Inc.), then treated ± 0.1 mg/ml subtilisin for 
30 min to remove predominantly β-tubulin C-terminal tails (CTTs), checked by western blot. The 
reaction was stopped by the addition of 10 mM pefabloc, and MTs were isolated by 
centrifugation. GFP-CKK domain binding was analyzed by TIRFM, using flow chambers 
assembled from plasma-cleaned glass coverslips and microscope slides. Chambers were 
incubated sequentially with 1 mg/ml PLL-PEG biotin (Susos AG), block solution (1% plurionic 
F-127, 4 mg/ml casein), 0.5 mg/ml neutravidin, and MTs ± CTTs (as indicated). Each incubation 
was followed by two washes with MRB80 buffer (80 mM PIPES, 4 mM MgCl2, and 1 mM 
EGTA [pH 6.8]) supplemented with 80 mM KCl, 20 μM paclitaxel, 4 mM DTT and 2 mg/ml 
casein. The final binding reaction contained 200 nM CKK-GFP in MRB80 with 80 mM KCl, 20 
μM taxol, 4 mM DTT and 2 mg/ml casein and an oxygen scavenger mix (400 μg/ml glucose 
oxidase, 200 μg/ml catalase). TIRFM was performed on an Eclipse Ti-E inverted microscope 
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with a Perfect Focus System, CFI Apo TIRF 1.49 N.A. oil objective, H-TIRF module and LU-N4 
laser unit (Nikon). Images were recorded with a 100 ms exposure on an iXon DU888 Ultra 
EMCCD camera (Andor) controlled with NIS-Elements AR Software (Nikon). 
 
Statistics and Reproducibility 
The precise p values for Mann-Whitney U test were calculated in Matlab (MathWorks). All data 
shown are mean ± SD. The sample size is indicated in the figure legends. All data presented in 
this study were either averages or representative data from at least two independent experiments.  
For the ssNMR experiments, all spectra were recorded twice on one sample and they were 
consistent. The sample did not alter by measuring the 1D H-C CP over time. A Life Sciences 
Reporting Summary for this article is available online. 
 
Code Availability 
The computer codes used in this study are available from the corresponding authors on request. 
 
Data Availability 
The structure of CKK3core was deposited in the PDBe databank under accession code 5LZN. The 
CKK-MT models along with their corresponding electron density maps are deposited in the PDB 
(CAMSAP1-CKK-MT, PDB: 5M54, CAMSAP1-N1492A-CKK-MT, PDB: 5M5C and 
CAMSAP3-CKK-MT, PDB: 5M50) and EMDB respectively (CAMSAP1-CKK-MT, EMDB: 
EMD-4156, CAMSAP1-N1492A-CKK-MT, EMDB: EMD-3444 and CAMSAP3-CKK-MT, 
EMDB: EMD-4154). NMR data were deposited in the Biological Magnetic Resonance Bank, 
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BMRB ID 27234. 
All data that support the conclusions are available from the authors on request, and/or available in 
the manuscript itself. Source data for the figures 1, 3, 4, 5 and 6 and supplementary figures S1, 
S4, S7, S8 and S9 can be found in Supplementary Table S2.  
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